TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 46 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,160 | +27900.0% | 21,169 | +80.0% | 0.00% | – |
| Q1 2023 | $22 | -100.0% | 11,760 | -65.8% | 0.00% | – |
| Q3 2022 | $57,000 | -62.0% | 34,390 | -54.3% | 0.00% | – |
| Q2 2022 | $150,000 | -72.2% | 75,228 | -46.1% | 0.00% | – |
| Q3 2021 | $540,000 | +26.8% | 139,477 | +169.3% | 0.00% | – |
| Q1 2021 | $426,000 | -75.6% | 51,794 | -65.3% | 0.00% | -100.0% |
| Q4 2020 | $1,744,000 | +387.2% | 149,090 | +115.6% | 0.00% | – |
| Q3 2020 | $358,000 | +153.9% | 69,165 | -3.6% | 0.00% | – |
| Q2 2020 | $141,000 | +193.8% | 71,775 | +148.2% | 0.00% | – |
| Q1 2020 | $48,000 | – | 28,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,518,371 | $16,344,000 | 2.72% |
| Ikarian Capital, LLC | 2,716,840 | $17,631,000 | 1.42% |
| Telemetry Investments, L.L.C. | 40,000 | $260,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $185,000 | 0.10% |
| Vigilare Wealth Management | 17,000 | $110,000 | 0.07% |
| X-Square Capital, LLC | 20,973 | $136,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 294,031 | $1,908,000 | 0.06% |
| Johnson & Johnson Innovation - JJDC, Inc. | 84,003 | $545,000 | 0.06% |
| NEA Management Company, LLC | 346,718 | $2,250,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 36,370 | $236,000 | 0.03% |